Practical implications of gene-expression-based assays for breast oncologists.
about
Regulation of mammary epithelial cell homeostasis by lncRNAsAndrogen Receptor: A Complex Therapeutic Target for Breast CancerMutation scanning using MUT-MAP, a high-throughput, microfluidic chip-based, multi-analyte panelSystemic, perioperative management of muscle-invasive bladder cancer and future horizons.Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.A data similarity-based strategy for meta-analysis of transcriptional profiles in cancer.The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics.Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer.Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset.Molecular genetics complexity impeding research progress in breast and ovarian cancers.PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance).Biological subtypes of breast cancer: Prognostic and therapeutic implications.Vimentin DNA methylation predicts survival in breast cancerHow many etiological subtypes of breast cancer: two, three, four, or more?Molecular features and survival outcomes of the intrinsic subtypes within HER2-positive breast cancerBioinformatic analysis reveals a pattern of STAT3-associated gene expression specific to basal-like breast cancers in human tumorsImmunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data.A generic cycling hypoxia-derived prognostic gene signature: application to breast cancer profiling.Tumour cell invasion: an emerging role for basal epithelial cell extrusion.Validation of the prognostic gene portfolio, ClinicoMolecular Triad Classification, using an independent prospective breast cancer cohort and external patient populations.Molecular Markers as Prognostic Factors in DCIS and Small Invasive Breast Cancers.Differential β₂-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell linesTumor microenvironment-associated modifications of alternative splicing.Use of formalin-fixed paraffin-embedded samples for gene expression studies in breast cancer patientsEvaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive valueCirculating miR-200c and miR-141 and outcomes in patients with breast cancer.Molecular characterization and targeted therapeutic approaches in breast cancerScience to practice: what do molecular biologic studies in rodent models add to our understanding of interventional oncologic procedures including percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists?Study design requirements for RNA sequencing-based breast cancer diagnosticsBreast cancer subtype predictors revisited: from consensus to concordance?Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery.Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breastIs breast cancer staging obsolete?PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer.The molecular profile of luminal B breast cancerConcordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen.Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy.Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer.Luminal B tumors are the most frequent molecular subtype in breast cancer of North African women: an immunohistochemical profile study from Morocco.
P2860
Q27011533-FB2924D4-2E48-4DF4-AB2B-2FF0BC1499C9Q28075188-AA0697DB-F6AE-4D78-A1D0-17170F15EDC4Q28484396-C9739DEC-A5F1-4B8B-B1D9-EBC8A9E1C475Q30240816-D45BF0C5-BD1D-4AD1-AECE-BA4635B58075Q30245184-681884D7-2DDD-460C-B498-81454B22F312Q30587056-6507FA3B-B8EF-4C82-BE3D-7E02DEB41FB5Q30978083-98DFF3FD-1471-4004-9056-DEDD66819165Q33573884-CE8F7B4A-CF7E-44D3-9F96-A4880EAEABABQ33591751-109E76D0-6C77-401E-9849-AC7237900BC1Q33674704-7AB80DE9-DC0B-4B38-B32E-DAE90BB647A5Q33858073-EC753021-D91C-4B49-9983-ED8867830E89Q33883406-9A3FDE03-8DE2-4360-8E97-90827B9A5B04Q34023695-4E150771-49D3-43AF-9C5C-8ED31F4EA95CQ34034767-AA2CAA36-C9D1-4F3D-9A12-E4E7C82F32C8Q34106175-ADA24BA7-2354-41E7-9CCC-59C809EEFE7CQ34120668-B580B12D-F4FD-49E7-8109-0ABD119998B6Q34144598-6EC88D2A-79CF-4A56-8506-E4155803F921Q34198351-0CAF8628-913C-4475-B2A9-52282F3C590FQ34334455-310FD470-2044-4FA9-A498-EF7838DCF586Q34425577-9DD64801-3CFA-496A-B121-B4715565E797Q34485047-C01A6320-BAEE-460B-8FB8-8B76DC69168BQ34576614-67423159-1F8A-41C3-9E0E-86FEDB9ECE67Q34654398-26F679C2-4E11-4A65-8AB0-48649E6DD5FAQ35066327-B0EA55AD-4E58-4295-80E4-3028734EDE98Q35284791-F143A2CE-26FB-40D4-8144-BC9D90DCEC12Q35503492-7D7389DB-82F2-4BB7-9F92-B667B5745529Q35518887-4B7E6989-4551-40B7-952A-2A4D25D9777BQ35530143-E519E476-C4B4-4644-B047-4EF48D9B3CBCQ35773556-84153C27-ED7D-4176-97C7-215510C81583Q35910164-17B89111-A333-4F8C-A957-A2C43CF84265Q36040448-F6274EAD-5713-43B2-9697-BB6C51C6886DQ36095773-A086015D-658B-4BC6-B9BC-C87521EB849BQ36113604-88242B24-470E-483E-9618-970356E62B7AQ36136837-404EC573-8C2E-480E-ABCF-A71AF6FB3331Q36147185-61DA9BFF-48F2-4F3A-8D03-7CC3D5354C0CQ36196676-5921B2FE-4874-4CE5-9945-5DBBB5C75C44Q36337751-C7D3D25A-C8B1-43CD-BB45-4379A0E3A158Q36383626-9513FD44-519B-4189-B27A-BE3F2C308E8CQ36494250-B5375601-69D8-43AD-8F47-9DAD140C3ADAQ36513217-D0695927-F784-45DC-B108-D6114700630C
P2860
Practical implications of gene-expression-based assays for breast oncologists.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Practical implications of gene-expression-based assays for breast oncologists.
@en
type
label
Practical implications of gene-expression-based assays for breast oncologists.
@en
prefLabel
Practical implications of gene-expression-based assays for breast oncologists.
@en
P2860
P1476
Practical implications of gene-expression-based assays for breast oncologists
@en
P2093
Matthew J Ellis
P2860
P356
10.1038/NRCLINONC.2011.178
P407
P577
2011-12-06T00:00:00Z